154 related articles for article (PubMed ID: 36985726)
1. Utilizing Estra-1,3,5,16-Tetraene Scaffold: Design and Synthesis of Nitric Oxide Donors as Chemotherapeutic Resistance Combating Agents in Liver Cancer.
Abou-Salim MA; Shaaban MA; Abd El Hameid MK; Alanazi MM; Halaweish F; Elshaier YAMM
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985726
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma.
Abou-Salim MA; Shaaban MA; Abd El Hameid MK; Elshaier YAMM; Halaweish F
Bioorg Chem; 2019 Apr; 85():515-533. PubMed ID: 30807895
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
Elshaier YAMM; Shaaban MA; Abd El Hamid MK; Abdelrahman MH; Abou-Salim MA; Elgazwi SM; Halaweish F
Bioorg Med Chem; 2017 Jun; 25(12):2956-2970. PubMed ID: 28487127
[TBL] [Abstract][Full Text] [Related]
4. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
6. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of harmine-nitric oxide donor derivatives as potential antitumor agents.
Li Z; Apizi Y; Zhang C; Wang Z; He H; Li X; Zhu Y; Yang J; Xiao L; Wang M
Bioorg Med Chem Lett; 2022 Jun; 65():128698. PubMed ID: 35341920
[TBL] [Abstract][Full Text] [Related]
9. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
10. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
12. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of 4-aniline quinazoline derivatives conjugated with hydrogen sulfide (H
Zheng YG; Zhang WQ; Meng L; Wu XQ; Zhang L; An L; Li CL; Gao CY; Xu L; Liu Y
Eur J Med Chem; 2020 Sep; 202():112522. PubMed ID: 32619886
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, toxicity and antitumor activity of cobalt carbonyl complexes targeting hepatocellular carcinoma.
Li J; Zhang J; Zhang Q; Wang Y; Bai Z; Zhao Q; He D; Wang Z; Zhang J; Chen Y
Bioorg Med Chem; 2019 Oct; 27(20):115071. PubMed ID: 31472989
[TBL] [Abstract][Full Text] [Related]
15. Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Chen Z; Huang KY; Ling Y; Goto M; Duan HQ; Tong XH; Liu YL; Cheng YY; Morris-Natschke SL; Yang PC; Yang SL; Lee KH
J Nat Prod; 2019 Nov; 82(11):3065-3073. PubMed ID: 31718182
[TBL] [Abstract][Full Text] [Related]
16. [Effects of nitric oxide on mitochondrial permeability transition and cytochrome C of human hepatocellular carcinoma cell lines].
Jiang XM; Zheng DL; Lin JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):519-23. PubMed ID: 15562764
[TBL] [Abstract][Full Text] [Related]
17. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
18. Exploration of thiazolidine-2,4-diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations.
Aziz NAAM; George RF; El-Adl K; Mahmoud WR
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200465. PubMed ID: 36403198
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative, -migratory and -clonogenic effects of long-lasting nitric oxide release in HepG2 cells.
Bormon R; Srivastava E; Ali R; Singh P; Kumar A; Verma S
Chem Commun (Camb); 2024 Mar; 60(26):3527-3530. PubMed ID: 38450546
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]